This stock worth a lot more than $32. I think with the strong balance sheet and solid pipeline of drugs, this stock should be trading closer to $35 by now. They should continue to buyback stock and raise the dividend soon. Takeover candidate IMO. PFE and MRK would love to have a pipeline like BMY.